mate and glp 1 GLP-1 medications may be trending, but your body already has its Yerba Mate: The Natural Complement

Tirzepatide (Mounjaro, Zepbound) Tirzepatide activates both GLP-1 and GIP receptors, providing stronger weight loss effects than semaglutide in head-to-head trials

(3) development of next-generation GLP-1 receptor-targeted therapeutics with enhanced specificity and reduced off-target effects [129132]

Patients aged 75 Years Old or Older The reduced cardiovascular and renal morbimortality associated with the use of GLP-1 RAs is beneficial for this particularly risky population [68,69,70,71,72,73]

These effects are often the result of slowed gastric emptyingthe very mechanism that increases satiety and reduces food intake

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

Due to the success of both dual-agonistic approaches, and the general high sequence homology between GLP-1, GIP, and glucagon, the next step in novel pharmaceutical development was the design of chimeric GLP-1R/GIPR/GcgR unimolecular triple-agonists [103], [178]